Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Trading Report for (STJ). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Jefferson Research
|
$20.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
St Jude Medical, Inc. Issues Q2 2012 EPS Guidance Above Analysts' Estimates; Raises FY 2012 EPS Guidance
St Jude Medical, Inc. announced that it expects its consolidated adjusted net earnings for the second quarter of 2012 to be in the range of $0.86 to $0.88 per diluted share and is raising fiscal 2012 guidance to be in the range of $3.44 to $3.49. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $0.85 for second quarter of 2012 and EPS of $3.52 for fiscal 2012.
Latest Developments for St. Jude Medical Inc
- St. Jude Medical Inc Issues Q2 2013 EPS Guidance In Line With Analysts' Estimates; Reaffirms FY 2013 EPS Guidance
- St. Jude Medical Inc Receives CE Mark Approval Of Deep Brain Stimulation Systems For Both Primary And Secondary Dystonia
- St. Jude Medical Inc Announces Public Offering of Senior Notes
- St. Jude Medical Inc Recalls Wire Used To Help Plug Hole In Heart-Reuters
- Share this
- Link this
- Digg this
Follow Reuters